Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study

BACKGROUND: FOLFIRINOX chemotherapy is the current Dutch standard of care for locally advanced (LAPC) and metastatic pancreatic cancer (PDAC) patients with good performance status. The objective of this study was to evaluate real-world response rates and survival in advanced PDAC and to assess condi...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Sijde, Fleur, van Dam, Jacob L., Groot Koerkamp, Bas, Haberkorn, Brigitte C. M., Homs, Marjolein Y. V., Mathijssen, Daniëlle, Besselink, Marc G., Wilmink, Johanna W., van Eijck, Casper H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283068/
https://www.ncbi.nlm.nih.gov/pubmed/35847365
http://dx.doi.org/10.1155/2022/8549487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283068/
https://www.ncbi.nlm.nih.gov/pubmed/35847365
http://dx.doi.org/10.1155/2022/8549487

Ejemplares similares